164 related articles for article (PubMed ID: 23857285)
1. Prognostic significance of cyclooxygenase-2 in osteosarcoma: a meta-analysis.
Jiao G; Ren T; Lu Q; Sun Y; Lou Z; Peng X; Liang W; Guo W
Tumour Biol; 2013 Oct; 34(5):2489-95. PubMed ID: 23857285
[TBL] [Abstract][Full Text] [Related]
2. The prognostic value of elevated ezrin in patients with osteosarcoma.
Lun DX; Hu YC; Xu ZW; Xu LN; Wang BW
Tumour Biol; 2014 Feb; 35(2):1263-6. PubMed ID: 24014052
[TBL] [Abstract][Full Text] [Related]
3. Cyclooxygenase-2 overexpression predicts poor survival in patients with high-grade extremity osteosarcoma: a pilot study.
Urakawa H; Nishida Y; Naruse T; Nakashima H; Ishiguro N
Clin Orthop Relat Res; 2009 Nov; 467(11):2932-8. PubMed ID: 19326179
[TBL] [Abstract][Full Text] [Related]
4. Quantitative assessment of the association of COX-2 (Cyclooxygenase-2) immunoexpression with prognosis in human osteosarcoma: a meta-analysis.
Wang Z; He M; Xiao Z; Wu H; Wu Y
PLoS One; 2013; 8(12):e82907. PubMed ID: 24358237
[TBL] [Abstract][Full Text] [Related]
5. Elevated long noncoding RNA HAGLROS expression correlates with clinical progression and prognosis in osteosarcoma.
Wu PF; Dai ZT; Liu WD; Zhao ZX; Kong YH
Eur Rev Med Pharmacol Sci; 2019 Feb; 23(4):1428-1433. PubMed ID: 30840263
[TBL] [Abstract][Full Text] [Related]
6. The relationship between the expression of Ki-67 and the prognosis of osteosarcoma.
Zeng M; Zhou J; Wen L; Zhu Y; Luo Y; Wang W
BMC Cancer; 2021 Mar; 21(1):210. PubMed ID: 33648449
[TBL] [Abstract][Full Text] [Related]
7. Association of MMP-2 expression and prognosis in osteosarcoma patients.
Zhang M; Zhang X
Int J Clin Exp Pathol; 2015; 8(11):14965-70. PubMed ID: 26823829
[TBL] [Abstract][Full Text] [Related]
8. Meta-analysis of serum lactate dehydrogenase and prognosis for osteosarcoma.
Fu Y; Lan T; Cai H; Lu A; Yu W
Medicine (Baltimore); 2018 May; 97(19):e0741. PubMed ID: 29742740
[TBL] [Abstract][Full Text] [Related]
9. Meta-analysis of clinical significance of p53 protein expression in patients with osteosarcoma.
Wu J; Guo A; Li Q; Wang D
Future Oncol; 2017 Sep; 13(21):1883-1891. PubMed ID: 28766969
[TBL] [Abstract][Full Text] [Related]
10. Prognostic significance of cyclooxygenase-2 in cervical cancer: a meta-analysis.
Huang M; Chen Q; Xiao J; Liu C; Zhao X
Int J Cancer; 2013 Jan; 132(2):363-73. PubMed ID: 22729746
[TBL] [Abstract][Full Text] [Related]
11. Does serum alkaline phosphatase level really indicate the prognosis in patients with osteosarcoma? A meta-analysis.
Gu R; Sun Y
J Cancer Res Ther; 2018 Jun; 14(Supplement):S468-S472. PubMed ID: 29970708
[TBL] [Abstract][Full Text] [Related]
12. Prognostic value of microRNAs in osteosarcoma: A meta-analysis.
Kim YH; Goh TS; Lee CS; Oh SO; Kim JI; Jeung SH; Pak K
Oncotarget; 2017 Jan; 8(5):8726-8737. PubMed ID: 28060730
[TBL] [Abstract][Full Text] [Related]
13. Cyclooxygenase-2 expression correlates with development, progression, metastasis, and prognosis of osteosarcoma: a meta-analysis and trial sequential analysis.
Wang S; Gao H; Zuo J; Gao Z
FEBS Open Bio; 2019 Feb; 9(2):226-240. PubMed ID: 30761249
[TBL] [Abstract][Full Text] [Related]
14. A systematic review of matrix metalloproteinase 9 as a biomarker of survival in patients with osteosarcoma.
Li H; Zhang K; Liu LH; Ouyang Y; Bu J; Guo HB; Xiao T
Tumour Biol; 2014 Jun; 35(6):5487-91. PubMed ID: 24577891
[TBL] [Abstract][Full Text] [Related]
15. Matrix metalloproteinase 9 expression and survival of patients with osteosarcoma: a meta-analysis.
Liu Y; Wang Y; Teng Z; Chen J; Li Y; Chen Z; Li Z; Zhang Z
Eur J Cancer Care (Engl); 2017 Jan; 26(1):. PubMed ID: 26239566
[TBL] [Abstract][Full Text] [Related]
16. Homogenous and Heterogenous Prognostic Factors for Patients with Bone Sarcoma.
Xu G; Wu H; Xu Y; Zhang Y; Lin F; Baklaushev VP; Chekhonin VP; Peltzer K; Wang X; Mao M; Wang G; Cui P; Zhang C
Orthop Surg; 2021 Feb; 13(1):134-144. PubMed ID: 33305494
[TBL] [Abstract][Full Text] [Related]
17. The role of vascular endothelial growth factor as a prognostic and clinicopathological marker in osteosarcoma: a systematic review and meta-analysis.
Zhang C; Wang L; Xiong C; Zhao R; Liang H; Luo X
J Orthop Surg Res; 2021 Dec; 16(1):738. PubMed ID: 34963495
[TBL] [Abstract][Full Text] [Related]
18. Altered long non-coding RNAs predict worse outcome in osteosarcoma patients: evidence from a meta-analysis.
Yang Y; Wang S; Li T
Oncotarget; 2017 May; 8(21):35234-35243. PubMed ID: 28415638
[TBL] [Abstract][Full Text] [Related]
19. Cyclooxygenase-2 expression does not correlate with outcome in osteosarcoma or rhabdomyosarcoma.
Dickens DS; Kozielski R; Leavey PJ; Timmons C; Cripe TP
J Pediatr Hematol Oncol; 2003 Apr; 25(4):282-5. PubMed ID: 12679640
[TBL] [Abstract][Full Text] [Related]
20. Letter regarding the article of Jiao G. J. et al. entitled "Prognostic significance of cyclooxygenase-2 in osteosarcoma: a meta-analysis".
He S; Xiao Z; Zeng G; Chen L
Tumour Biol; 2014 Jul; 35(7):6187-9. PubMed ID: 24816920
[No Abstract] [Full Text] [Related]
[Next] [New Search]